Article
Genetic variants of GSK3B are associated with biomarkers for Alzheimer's disease and cognitive function.
Journal of Alzheimer's disease : JAD - 1 Jan 2015
Kettunen Petronella, Larsson Susanna, Holmgren Sandra, Olsson Sandra, Minthon Lennart, Zetterberg Henrik, Blennow Kaj, Nilsson Staffan, Sjölander Annica
Abstract excerpt
BACKGROUND: Glycogen synthase kinase 3 beta (GSK3B) is the major kinase phosphorylating tau protein. Hyperphosphorylated tau is one of the hallmarks of Alzheimer's disease (AD). Despite extensive research, the role of GSK3B in AD pathogenesis is not fully understood. OBJECTIVE: To evaluate possible associations between gene variants of GSK3B and risk of AD. METHODS: Twelve GSK3B tag single-nucleotide...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
